Whistleblower Public Court Documents
Two False Claims Act (FCA) Qui Tam Whistleblower Cases
Links to public Whistleblower Court documents:
District of Rhode Island (D-RI) – U.S. Multiple Sclerosis (MS) brand drugs
- D-RI Second Amended Complaint; August 2018
- Pharmaceutical Defendant Motion to Dismiss; November 19, 2018
- PBM Defendant Motion to Dismiss; November 19, 2018
- Biogen Supplemental Motion to Dismiss; November 19, 2018
- Department of Justice (DOJ) Motion to Dismiss; December 21, 2018
- Relator Opposition to DOJ Motion to Dismiss; January 11, 2019
- John R. Borzilleri, M.D. Affidavit in Opposition to DOJ Motion to Dismiss; January 13, 2019
- Relator Opposition to Defendants' Motion to Dismiss; February 3, 2019
- Relator Opposition to Biogen Motion to Dismiss; February 5, 2019
- DOJ Reply further in Support of its Motion to Dismiss; February 6, 2019
- Manufacturer Defendant Reply to Relator's Opposition to Motion to Dismiss; March 21, 2019
- PBM Defendant Reply to Relator's Opposition to Motion to Dismiss; March 21, 2019
- Biogen Reply to Relator's Opposition to Motion to Dismiss; March 21, 2019
- Transcript of District Court hearing regarding DOJ Motion to Dismiss; September 26, 2019
- Court Order/Opinion Granting DOJ Motion to Dismiss; October 21, 2019
Southern District of New York (SDNY) – U.S. Cancer, Insulin, Rheumatoid Arthritis and other brand drugs
- SDNY Amended Complaint; August 2018
- Pharmaceutical Defendant Motion to Dismiss; October 2, 2018
- PBM Defendant Motion to Dismiss; October 1, 2018
- Relator Opposition to Defendants’ Motion to Dismiss; November 19, 2018
- Department of Justice (DOJ) Motion to Dismiss; December 21, 2018
- Manufacturer Defendant Reply to Relator's Opposition to Motion to Dismiss; January 4, 2019
- PBM Defendant Reply to Relator's Opposition to Motion to Dismiss; January 4, 2019
- Relator Opposition to DOJ Motion to Dismiss; January 11, 2019
- John R. Borzilleri, M.D. Affidavit in Opposition to DOJ Motion to Dismiss; January 13, 2019
- DOJ Reply regarding its Motion to Dismiss; February 6, 2019
- Court Order/Opinion Granting DOJ Motion to Dismiss; July 16, 2019
- Our Brief filed with the Second Circuit Court of Appeals seeking reversal of DOJ's dismissal of the qui tam case; December 23, 2019